Wroclaw Medical University joined a research program on the effect of chloroquine in the prevention or reduction of pulmonary complications in the course of COVID-19. This week, the first patient was qualified for the study to be conducted in several centres in Poland.
According to the British public health agency, in addition to those suffering from asthma, chronic heart disease and kidney disease, pregnant women are also among those at increased risk of severe illness from coronavirus. Increased risk means not only a greater chance of infection, but also the severe course of the disease. But although the future mother's health and well-being can be monitored relatively easily, for the foetus the process is more complicated.